Uropathology European Urology

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Volume 62, Issue 4, Pages (October 2012)
The PSA Era is not Over for Prostate Cancer
Volume 59, Issue 2, Pages (February 2011)
Volume 50, Issue 1, Pages (July 2006)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
2327 PROSTATE CANCER STAGE, GRADE AND POSITIVE MARGIN RATE IN MEN WITH PSA ≥ 1 ng/ml UNDERGOING RADICAL PROSTATECTOMY: POPULATION DATA ANALYSIS  Sergey.
Volume 44, Issue 6, Pages (December 2003)
Volume 53, Issue 4, Pages (April 2008)
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections  Rodolfo Montironi,
Volume 46, Issue 3, Pages (September 2004)
Volume 53, Issue 5, Pages (May 2008)
Volume 51, Issue 4, Pages (April 2007)
Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Volume 61, Issue 2, Pages (February 2012)
Prostate Cancer Epidemic in Sight?
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 189, Issue 1, Pages (January 2013)
Volume 53, Issue 2, Pages (February 2008)
Bladder Cancer: A Major Public Health Issue
Training in Laparoscopy
Volume 54, Issue 4, Pages (October 2008)
Pseudohyperplastic Adenocarcinoma of the Prostate
Pitfalls of Pathologic Staging in Prostate Cancer
Volume 63, Issue 6, Pages (June 2013)
Volume 62, Issue 3, Pages (September 2012)
Prostate Cancer Detection: A View of the Future
Volume 68, Issue 3, Pages (September 2015)
Volume 67, Issue 3, Pages (March 2015)
Volume 61, Issue 4, Pages (April 2012)
Volume 71, Issue 6, Pages (June 2017)
Counselling the Prostate Cancer Patient
Volume 54, Issue 2, Pages (August 2008)
Laurent Boccon-Gibod  European Urology Supplements 
Volume 53, Issue 4, Pages (April 2008)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer  I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,
Volume 53, Issue 4, Pages (April 2008)
Volume 61, Issue 2, Pages (February 2012)
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Volume 41, Issue 2, Pages (February 2002)
Richard C. Harkaway  European Urology Supplements 
TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential  Liang Cheng, Rodolfo Montironi,
Volume 50, Issue 5, Pages (November 2006)
Volume 50, Issue 3, Pages (September 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Optimising Hormone Therapy in Advanced Disease
Biopsy of the Vesico-Urethral Anastomosis after Radical Prostatectomy: When and How  Vincenzo Scattoni, Marco Roscigno, Marco Raber, Paolo Consonni, Luigi.
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
How and When to Take Prostate Biopsies
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Luis Martínez-Piñeiro  European Urology 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
Volume 53, Issue 2, Pages (February 2008)
Joaquim Bellmunt  European Urology Supplements 
Computer Simulation of Prostate Biopsies
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Epidemiology and Demographics of Prostatitis
Does PSA Testing Influence the Natural History of Prostate Cancer?
Volume 51, Issue 5, Pages (May 2007)
Volume 23, Issue 1, Pages vii-ix (January 2015)
Presentation transcript:

Uropathology European Urology L Boccon-Gibod, F Algaba, F.C Hamdy  European Urology  Volume 43, Issue 2, Pages I-IX (February 2003) DOI: 10.1016/S0302-2838(02)00371-8

Fig. 1 WHO/ISUP 1988 grading system—PNLMP: papillary neoplasm of low malignancy; LG: low grade; HG: high grade. European Urology 2003 43, I-IXDOI: (10.1016/S0302-2838(02)00371-8)

Fig. 2 WHO 1999 classification—PNLMP: papillary neoplasm of low malignancy; GI: grade 1; GII: grade 2; GIII: grade 3. European Urology 2003 43, I-IXDOI: (10.1016/S0302-2838(02)00371-8)

Fig. 3 Prostate biopsy sampling scheme. European Urology 2003 43, I-IXDOI: (10.1016/S0302-2838(02)00371-8)

Fig. 4 High grade PIN. European Urology 2003 43, I-IXDOI: (10.1016/S0302-2838(02)00371-8)

Fig. 5 Positive margins at radical prostatectomy. European Urology 2003 43, I-IXDOI: (10.1016/S0302-2838(02)00371-8)